Answer to the letter “Competing mortality and the interpretation of similar non-fatal MACE risk with second-generation BTK inhibitors” from Hasan Burak Isleyen and Zehra Sucuoglu
European Heart Journal – Cardio-Oncology · 2026
DOI: 10.1093/ehjco/aabag017 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Heart Journal – Cardio-Oncology, 2026. Verfasst von Joachim Alexandre und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Alexandre, J., & Fauchier, L. (2026). Answer to the letter “Competing mortality and the interpretation of similar non-fatal MACE risk with second-generation BTK inhibitors” from Hasan Burak Isleyen and Zehra Sucuoglu. European Heart Journal – Cardio-Oncology. https://doi.org/10.1093/ehjco/aabag017
Vancouver
Alexandre J, Fauchier L. Answer to the letter “Competing mortality and the interpretation of similar non-fatal MACE risk with second-generation BTK inhibitors” from Hasan Burak Isleyen and Zehra Sucuoglu. European Heart Journal – Cardio-Oncology. 2026. doi:10.1093/ehjco/aabag017
BibTeX
@article{Alexandre2026,
author = {Alexandre, Joachim and Fauchier, Laurent},
title = {Answer to the letter “Competing mortality and the interpretation of similar non-fatal MACE risk with second-generation BTK inhibitors” from Hasan Burak Isleyen and Zehra Sucuoglu},
journal = {European Heart Journal – Cardio-Oncology},
year = {2026},
doi = {10.1093/ehjco/aabag017}
}
EUVIMED